文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

重症脓毒症患者持续性炎症与贫血

Persistent inflammation and anemia among critically ill septic patients.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论重症脓毒症患者持续性炎症细胞因子升高与铁限制性小细胞性贫血相关,且不依赖内源性促红细胞生成素。

这项前瞻性观察性队列研究纳入42例重症脓毒症患者,比较调整后ΔHb(校正手术失血、采血失血和红细胞输注量)大于0组(n=18)与小于等于0组(n=24)。负向AdjΔHb组第14天IL-6、IL-8和粒细胞集落刺激因子水平显著更高,但促红细胞生成素无差异;该组第4、7、14天平均红细胞体积显著更低,而血清转铁蛋白受体水平相似。线性回归显示较低AdjΔHb与第14天较高IL-6、IL-8、基质细胞衍生因子1和肿瘤坏死因子α相关,但与促红细胞生成素无关。作者认为持续性炎症细胞因子升高与铁限制性贫血相关,发生在无全身性铁缺乏且不依赖内源性促红细胞生成素的情况下。

要点

  • 负向AdjΔHb组第14天IL-6(37.4 vs 15.2 pg/mL, p<0.05)、IL-8(39.1 vs 18.2 pg/mL, p=0.01)和粒细胞集落刺激因子(101.3 vs 60.5 pg/mL, p=0.01)显著高于正向AdjΔHb组,促红细胞生成素无差异。
  • 负向AdjΔHb组第4天(89.6 vs 93.2 fL/cell, p=0.04)、第7天(92.3 vs 94.9 fL/cell, p=0.04)和第14天(92.1 vs 96.0 fL/cell, p=0.03)平均红细胞体积显著低于正向AdjΔHb组,血清转铁蛋白受体水平相似。
  • 线性回归显示较低AdjΔHb与第14天较高IL-6(r=0.22, p<0.01)、IL-8(r=0.10, p=0.04)、基质细胞衍生因子1(r=0.14, p=0.02)和肿瘤坏死因子α(r=0.13, p=0.02)相关,与促红细胞生成素无关。
  • 该研究为前瞻性观察性队列,证据等级为预后研究II级,提示重症脓毒症贫血可能由持续性炎症驱动而非铁缺乏或促红细胞生成素不足。

适用人群与场景

  • 重症脓毒症成人患者,来自前瞻性观察性队列研究,共42例。

诊断标准与关键阈值

  • 以脓毒症发病时和出院时血红蛋白计算ΔHb,再按300 mL红细胞相当于1 g/dL血红蛋白校正手术失血、采血失血和红细胞输注量,得到调整后ΔHb(AdjΔHb)。
  • AdjΔHb大于0为正向AdjΔHb组(n=18),AdjΔHb小于等于0为负向AdjΔHb组(n=24)。

研究设计与关键结果

  • 前瞻性观察性队列研究,42例重症脓毒症患者,比较正向AdjΔHb组(n=18)与负向AdjΔHb组(n=24)。
  • 负向AdjΔHb组第14天IL-6(37.4 vs 15.2 pg/mL, p<0.05)、IL-8(39.1 vs 18.2 pg/mL, p=0.01)和粒细胞集落刺激因子(101.3 vs 60.5 pg/mL, p=0.01)显著高于正向AdjΔHb组,促红细胞生成素无显著差异。
  • 负向AdjΔHb组第4天平均红细胞体积(89.6 vs 93.2 fL/cell, p=0.04)、第7天(92.3 vs 94.9 fL/cell, p=0.04)和第14天(92.1 vs 96.0 fL/cell, p=0.03)显著低于正向AdjΔHb组,血清转铁蛋白受体水平相似。
  • 线性回归显示较低AdjΔHb与第14天较高IL-6(r=0.22, p<0.01)、IL-8(r=0.10, p=0.04)、基质细胞衍生因子1(r=0.14, p=0.02)和肿瘤坏死因子α(r=0.13, p=0.02)相关,与促红细胞生成素无关。

证据类型、等级与局限

  • 证据类型:前瞻性观察性队列研究;证据等级:预后研究,level II。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为持续性炎症细胞因子升高与重症脓毒症患者铁限制性贫血相关,发生在无全身性铁缺乏且不依赖内源性促红细胞生成素的情况下。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Associations among inflammatory cytokines, erythropoietin (EPO), and anemia in critically ill septic patients remain unclear. This study tested the hypothesis that elevated inflammatory cytokines and decreased EPO would be associated with iron-restricted anemia while accounting for operative blood loss, phlebotomy blood loss, and red blood cell (RBC) transfusion volume.

METHODS: Prospective observational cohort study of 42 critically ill septic patients was conducted. Hemoglobin (Hb) at sepsis onset and hospital discharge were used to calculate ΔHb. Operative blood loss, phlebotomy blood loss, and RBC transfusion volume were used to calculate adjusted ΔHb (AdjΔHb) assuming that 300 mL RBC is equal to 1 g/dL Hb. Patients with AdjΔHb of greater than 0 (positive AdjΔHb, n = 18) were compared with patients with AdjΔHb of less than or equal to 0 (negative AdjΔHb, n = 24).

RESULTS: Plasma tumor necrosis factor α, granulocyte colony-stimulating factor, interleukin (IL)-6, IL-8, EPO, erythrocyte mean corpuscular volume, and serum transferrin receptor were measured on days 0, 1, 4, 7, and 14. Patients with negative AdjΔHb had significantly higher day 14 levels of IL-6 (37.4 vs. 15.2 pg/mL, p < 0.05), IL-8 (39.1 vs. 18.2 pg/mL, p = 0.01), and granulocyte colony-stimulating factor (101.3 vs. 60.5 pg/mL, p = 0.01), but not EPO. On linear regression analysis, lower AdjΔHb was associated with higher day 14 levels of IL-6 (r = 0.22, p < 0.01), IL-8 (r = 0.10, p = 0.04), stromal cell-derived factor 1 (r = 0.14, p = 0.02), and tumor necrosis factor α (r = 0.13, p = 0.02), but not EPO. Patients with negative AdjΔHb had significantly lower mean corpuscular volume on days 4 (89.6 vs. 93.2 fL/cell, p = 0.04), 7 (92.3 vs. 94.9 fL/cell, p = 0.04), and 14 (92.1 vs. 96.0 fL/cell, p = 0.03) but similar serum transferrin receptor levels.

CONCLUSION: Persistent elevation of inflammatory cytokines was associated with iron-restricted anemia among critically ill septic patients, occurring in the absence of systemic iron deficiency, independent of endogenous EPO.

LEVEL OF EVIDENCE: Prognostic study, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Loftus TJ, Mira JC, Stortz JA, et al. Persistent inflammation and anemia among critically ill septic patients. J Trauma Acute Care Surg. 2019. PMID: 30489504. doi:10.1097/TA.0000000000002147

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。